# Bidirectional regulation of lipid metabolism and the tumor microenvironment: new perspectives from mechanism to therapy

**Authors:** Kaixin Shi, Bing Pan, Ruixin Zheng, Kaiyi Liu, Jincheng Song, Xiaobo Wang, Li Li

PMC · DOI: 10.3389/fimmu.2025.1696102 · Frontiers in Immunology · 2025-11-11

## TL;DR

This review explores how lipid metabolism in cancer cells and immune cells within the tumor microenvironment interact and influence cancer progression and immune responses.

## Contribution

The paper highlights the bidirectional regulation of lipid metabolism and the tumor microenvironment, proposing new therapeutic strategies combining metabolic inhibitors with immunotherapy.

## Key findings

- Lipid metabolism supports cancer cell proliferation and metastasis.
- Lipid metabolism modulates immune cell function in the tumor microenvironment.
- Combining metabolic enzyme inhibitors with immunotherapy may enhance antitumor responses.

## Abstract

The role of lipid metabolism in cancer and immune regulation has received significant attention in recent years. Reprogramming of lipid metabolism is one of the key hallmarks of cancer and plays a critical role in cancer progression by supporting the rapid proliferation, survival, and metastasis of tumor cells. Importantly, beyond its well-established functions in cancer cells, lipid metabolism dynamically regulates the functions of various immune cells within the TME (e.g., T cells, natural killer cells, macrophages), thereby molding antitumor immune responses. This review combines the contemporary awareness of the reciprocal interactions between lipid metabolism and the TME. We start with a simple overview of key lipid metabolic pathways in cancer cells, followed by an in-depth exploration of the way lipid uptake, synthesis, and oxidation influence the fate and role of tumor-infiltrating immune. We also appraise the translational potential of targeting lipid metabolism and propose that combining inhibitors of key metabolic enzymes, for example fatty acid synthase or acetyl-CoA carboxylase, with immunotherapy can not only effectively alleviate immunosuppression but also overcome immunosuppression. Finally, we spotlight the remaining knowledge gaps and put forward future research priorities and potential. Intervening in lipid metabolic interactions represents a promising prospect for developing the novel cancer treatment strategies.

## Linked entities

- **Proteins:** FASN1 (Fatty acid synthase 1), CAC2 (acetyl Co-enzyme a carboxylase biotin carboxylase subunit)

## Full-text entities

- **Genes:** FASN (fatty acid synthase) [NCBI Gene 2194] {aka FAS, OA-519, SDR27X1}
- **Diseases:** metastasis (MESH:D009362), cancer (MESH:D009369)
- **Chemicals:** lipid (MESH:D008055)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12644080/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12644080/full.md

## References

157 references — full list in the complete paper: https://tomesphere.com/paper/PMC12644080/full.md

---
Source: https://tomesphere.com/paper/PMC12644080